C191H281N35O14S7 — CID 159574885
N-[4-(5-butyl-2-ethoxyphenyl)-1,3-thiazol-2-yl]-4-[(1-methylpiperidin-3-yl)methyl]piperazine-1-carboxamide;N-[4-(5-butyl-2-methoxyphenyl)-1,3-thiazol-2-yl]-4-[(1-methylpiperidin-3-yl)methyl]piperazine-1-carboxamide;N-[4-(5-cyclohexyl-2-ethoxyphenyl)-1,3-thiazol-2-yl]-4-[(1-methylpiperidin-3-yl)methyl]piperazine-1-carboxamide;N-[4-(5-cyclopentyl-2-ethoxyphenyl)-1,3-thiazol-2-yl]-4-[(1-methylpiperidin-3-yl)methyl]piperazine-1-carboxamide;N-[4-(5-cyclopentyl-2-ethoxyphenyl)-1,3-thiazol-2-yl]-4-(2-pyrrolidin-1-ylethyl)piperazine-1-carboxamide;N-[4-(5-cyclopentyl-2-methoxyphenyl)-1,3-thiazol-2-yl]-4-[(1-methylpiperidin-3-yl)methyl]piperazine-1-carboxamide;N-[4-(5-cyclopentyl-2-methoxyphenyl)-1,3-thiazol-2-yl]-4-[(1-methylpiperidin-4-yl)methyl]piperazine-1-carboxamide (PubChem CID 159574885) has the molecular formula C191H281N35O14S7 and a molecular weight of 3516.05 g/mol. Its IUPAC name is N-[4-(5-butyl-2-ethoxyphenyl)-1,3-thiazol-2-yl]-4-[(1-methylpiperidin-3-yl)methyl]piperazine-1-carboxamide;N-[4-(5-butyl-2-methoxyphenyl)-1,3-thiazol-2-yl]-4-[(1-methylpiperidin-3-yl)methyl]piperazine-1-carboxamide;N-[4-(5-cyclohexyl-2-ethoxyphenyl)-1,3-thiazol-2-yl]-4-[(1-methylpiperidin-3-yl)methyl]piperazine-1-carboxamide;N-[4-(5-cyclopentyl-2-ethoxyphenyl)-1,3-thiazol-2-yl]-4-[(1-methylpiperidin-3-yl)methyl]piperazine-1-carboxamide;N-[4-(5-cyclopentyl-2-ethoxyphenyl)-1,3-thiazol-2-yl]-4-(2-pyrrolidin-1-ylethyl)piperazine-1-carboxamide;N-[4-(5-cyclopentyl-2-methoxyphenyl)-1,3-thiazol-2-yl]-4-[(1-methylpiperidin-3-yl)methyl]piperazine-1-carboxamide;N-[4-(5-cyclopentyl-2-methoxyphenyl)-1,3-thiazol-2-yl]-4-[(1-methylpiperidin-4-yl)methyl]piperazine-1-carboxamide.
| Compound Name | N-[4-(5-butyl-2-ethoxyphenyl)-1,3-thiazol-2-yl]-4-[(1-methylpiperidin-3-yl)methyl]piperazine-1-carboxamide;N-[4-(5-butyl-2-methoxyphenyl)-1,3-thiazol-2-yl]-4-[(1-methylpiperidin-3-yl)methyl]piperazine-1-carboxamide;N-[4-(5-cyclohexyl-2-ethoxyphenyl)-1,3-thiazol-2-yl]-4-[(1-methylpiperidin-3-yl)methyl]piperazine-1-carboxamide;N-[4-(5-cyclopentyl-2-ethoxyphenyl)-1,3-thiazol-2-yl]-4-[(1-methylpiperidin-3-yl)methyl]piperazine-1-carboxamide;N-[4-(5-cyclopentyl-2-ethoxyphenyl)-1,3-thiazol-2-yl]-4-(2-pyrrolidin-1-ylethyl)piperazine-1-carboxamide;N-[4-(5-cyclopentyl-2-methoxyphenyl)-1,3-thiazol-2-yl]-4-[(1-methylpiperidin-3-yl)methyl]piperazine-1-carboxamide;N-[4-(5-cyclopentyl-2-methoxyphenyl)-1,3-thiazol-2-yl]-4-[(1-methylpiperidin-4-yl)methyl]piperazine-1-carboxamide |
|---|---|
| PubChem CID | 159574885 |
| Molecular Formula | C191H281N35O14S7 |
| Molecular Weight | 3516.05 g/mol |
| Exact Mass | 3513.04 |
| IUPAC Name | N-[4-(5-butyl-2-ethoxyphenyl)-1,3-thiazol-2-yl]-4-[(1-methylpiperidin-3-yl)methyl]piperazine-1-carboxamide;N-[4-(5-butyl-2-methoxyphenyl)-1,3-thiazol-2-yl]-4-[(1-methylpiperidin-3-yl)methyl]piperazine-1-carboxamide;N-[4-(5-cyclohexyl-2-ethoxyphenyl)-1,3-thiazol-2-yl]-4-[(1-methylpiperidin-3-yl)methyl]piperazine-1-carboxamide;N-[4-(5-cyclopentyl-2-ethoxyphenyl)-1,3-thiazol-2-yl]-4-[(1-methylpiperidin-3-yl)methyl]piperazine-1-carboxamide;N-[4-(5-cyclopentyl-2-ethoxyphenyl)-1,3-thiazol-2-yl]-4-(2-pyrrolidin-1-ylethyl)piperazine-1-carboxamide;N-[4-(5-cyclopentyl-2-methoxyphenyl)-1,3-thiazol-2-yl]-4-[(1-methylpiperidin-3-yl)methyl]piperazine-1-carboxamide;N-[4-(5-cyclopentyl-2-methoxyphenyl)-1,3-thiazol-2-yl]-4-[(1-methylpiperidin-4-yl)methyl]piperazine-1-carboxamide |
| SMILES | CCCCc1ccc(OC)c(-c2csc(NC(=O)N3CCN(CC4CCCN(C)C4)CC3)n2)c1.CCCCc1ccc(OCC)c(-c2csc(NC(=O)N3CCN(CC4CCCN(C)C4)CC3)n2)c1.CCOc1ccc(C2CCCC2)cc1-c1csc(NC(=O)N2CCN(CC3CCCN(C)C3)CC2)n1.CCOc1ccc(C2CCCC2)cc1-c1csc(NC(=O)N2CCN(CCN3CCCC3)CC2)n1.CCOc1ccc(C2CCCCC2)cc1-c1csc(NC(=O)N2CCN(CC3CCCN(C)C3)CC2)n1.COc1ccc(C2CCCC2)cc1-c1csc(NC(=O)N2CCN(CC3CCCN(C)C3)CC2)n1.COc1ccc(C2CCCC2)cc1-c1csc(NC(=O)N2CCN(CC3CCN(C)CC3)CC2)n1 |
| InChI | InChI=1S/C29H43N5O2S.C28H41N5O2S.3C27H39N5O2S.C27H41N5O2S.C26H39N5O2S/c1-3-36-27-12-11-24(23-9-5-4-6-10-23)18-25(27)26-21-37-28(30-26)31-29(35)34-16-14-33(15-17-34)20-22-8-7-13-32(2)19-22;1-3-35-26-11-10-23(22-8-4-5-9-22)17-24(26)25-20-36-27(29-25)30-28(34)33-15-13-32(14-16-33)19-21-7-6-12-31(2)18-21;1-30-11-5-6-20(17-30)18-31-12-14-32(15-13-31)27(33)29-26-28-24(19-35-26)23-16-22(9-10-25(23)34-2)21-7-3-4-8-21;1-30-11-9-20(10-12-30)18-31-13-15-32(16-14-31)27(33)29-26-28-24(19-35-26)23-17-22(7-8-25(23)34-2)21-5-3-4-6-21;1-2-34-25-10-9-22(21-7-3-4-8-21)19-23(25)24-20-35-26(28-24)29-27(33)32-17-15-31(16-18-32)14-13-30-11-5-6-12-30;1-4-6-8-21-10-11-25(34-5-2)23(17-21)24-20-35-26(28-24)29-27(33)32-15-13-31(14-16-32)19-22-9-7-12-30(3)18-22;1-4-5-7-20-9-10-24(33-3)22(16-20)23-19-34-25(27-23)28-26(32)31-14-12-30(13-15-31)18-21-8-6-11-29(2)17-21/h11-12,18,21-23H,3-10,13-17,19-20H2,1-2H3,(H,30,31,35);10-11,17,20-22H,3-9,12-16,18-19H2,1-2H3,(H,29,30,34);9-10,16,19-21H,3-8,11-15,17-18H2,1-2H3,(H,28,29,33);7-8,17,19-21H,3-6,9-16,18H2,1-2H3,(H,28,29,33);9-10,19-21H,2-8,11-18H2,1H3,(H,28,29,33);10-11,17,20,22H,4-9,12-16,18-19H2,1-3H3,(H,28,29,33);9-10,16,19,21H,4-8,11-15,17-18H2,1-3H3,(H,27,28,32) |
| InChIKey | MIGVANWXTGZJQO-UHFFFAOYSA-N |
| XLogP | 35.85 |
| TPSA | 426.58 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 42 |
| Rotatable Bonds | 51 |
| Heavy Atoms | 247 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3516.05 |
| LogP ≤ 5 | 35.85 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 42 |